Prostate Irreversible Electroporation Study
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Conventional treatment options for localized prostate cancer include prostatectomy, radiotherapy and active surveillance. However, prostatectomy and radiotherapy carry certain degree of morbidity, including the risks of urinary incontinence, erectile dysfunction and injury to the structures in the proximity. Active surveillance carries the risk of disease progression and psychological distress to the patients. Focal therapy employs the concept of only destroying the significant lesion, resulting in disease cure and improved functional outcome. Among the different options of focal therapy, Irreversible electroporation has evolved over the past decades and can be a reliable treatment option. Our study aims at assess the safety and effectiveness of such treatment in prostate cancer management.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Mężczyźni w wieku 40-85 lat
- •Widoczny guz na badaniu MRI
- •Potwierdzony rak prostaty w wczesnym stadium (zanim rozprzestrzeni się poza gruczoł)
- •Wynik skali Gleasona nie wyższy niż 7 (wskaźnik agresywności nowotworu)
- •Poziom PSA nie wyższy niż 20 ng/ml (wskaźnik w krwi)
✗ Disqualifies
- •Niemożliwość wykonania badania MRI z środkiem kontrastowym
- •Aktywne infekcje układu moczowego
- •Choroby pęcherza moczowego, kamienie w pęcherzu lub rak pęcherza
- •Zwężenie cewki moczowej
- •Zaburzenia kontroli pęcherza i zwieracza z przyczyn neurologicznych
Simplified criteria — AI translation
Trial details
- Minimum age
- 40 Years
- Maximum age
- 85 Years
- Last updated (source)
- September 10, 2026
- Sex
- Male only
Therapies / drugs in trial
Locations (1)
Prince of Wales Hospital, the Chinese University of Hong Kong
Hong Kong, Hong Kong
Trial contact
Chi Hang Yee, MBBS
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/11/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.